NYGC logo
NYGC logo for sticky header
Our Policies
Terms & Conditions
Privacy Policy
Careers
Contact Us
Support Us
close
Careers
Contact Us
Support Us
About Us
About Us
About Us
Our People
Our Commitment to Diversity, Equity, and Inclusion
Our Donors
Our Facility
Member Institutions
close
Research Areas
Research Areas
All Research Areas
Cancer
Computational Genomics
COVID-19 Genomics
Genomic Technologies
Neurodegenerative Disease
Neuropsychiatric Disease
close
Labs
Labs
All Labs
Faculty Labs
Center for Genomics of Neurodegenerative Disease – Phatnani Lab
Gürsoy Lab
Imieliński Lab
Iossifov Lab
Knowles Lab
Landau Lab
Lappalainen Lab
Sanjana Lab
Satija Lab
Singh Lab
Vicković Lab
Wigler Lab
Zhu Lab
NYGC Labs
Clinical Lab
Computational Biology Lab / Bioinformatics
Research Sequencing
Technology Innovation Lab
close
Publications
News
Events
Partner with Us
Partner with Us
Collaborative Research
Affiliate Membership Program
Research Sequencing
Industry & Foundation Collaborations
Academic Collaborations
Disease-specific Consortia
Tech Transfer
Sponsored Research
Clinical Lab
close
Search
close
News
Filter
(
0
)
CLEAR
Years
(
0
)
2023
2022
2021
2020
2019
2018
2017
2016
2015
CLEAR
Lab Groups
(
0
)
Singh Lab
Vicković Lab
Clinical Lab
Computational Biology
Gürsoy Lab
Imieliński Lab
Innovation Lab
Iossifov Lab
Knowles Lab
Landau Lab
Lappalainen Lab
Center for Genomics of Neurodegenerative Disease - Phatnani Lab
Sanjana Lab
Satija Lab
Wigler Lab
Zhu Lab
NYGC ALS Consortium
NYGC Polyethnic-1000 Initiative
CLEAR
Research Areas
(
0
)
Cancer
Computational Genomics
COVID-19 Genomics
Genomic Technologies
Neurodegenerative Disease
Neuropsychiatric Disease
Population Genomics
Technology Innovation
CLEAR
31
Results
(Filters Applied)
CLEAR ALL
Sanjana Lab
x
Whole Exome Sequencing Predicts Whether Patients Respond to Cancer Immunotherapy
Programming the Immune System to Supercharge Cancer Cell Therapies
Sanjana Lab of NYGC/NYU Extends RNA-Targeting CRISPR-Cas13 Genomics Tools to Model Organisms and Viruses Including SARS-CoV-2
Sanjana Lab of NYGC/NYU Boosts Gene Knockdown in Human Cells With CRISPR-Cas13 Using Chemically-Modified Guide RNAs
Dr. Neville Sanjana Interviewed in “What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health” Feature Article
Single-Cell CRISPR Technology Deciphers Role of Chromatin Accessibility in Cancer
Load More
